Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nevro Corp (NVRO)
:NVRO
Holding NVRO?
Track your performance easily
Earnings Data
Report Date
Feb 19, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.78Last Year’s EPS
-0.25Same Quarter Last Year
Based on 11 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 05, 2018
|% Change Since: -14.10%
|Next Earnings Date:Aug 02, 2018
Earnings Call Sentiment|Neutral
The earnings call highlighted significant progress in cost management, cash position improvement, and new product launches like HFX AdaptivAI, which show promise for future growth. However, the company faced challenges with declining revenue and trial procedures, competitive pressures, and international market issues. While the company is optimistic about its strategic initiatives and new technology, market challenges remain a concern.Company Guidance
During Nevro Corp.'s third quarter 2024 earnings call, the company provided guidance indicating a maintained full-year revenue forecast of $400 million to $405 million, reflecting a decrease of approximately 5% to 6% from 2023. The guidance considers ongoing market challenges and impacts from decreased direct-to-consumer (DTC) marketing spend. The company reported a worldwide revenue decrease of 6.7% compared to the third quarter of 2023, with U.S. revenue down by 6.5% and U.S. spinal cord stimulation (SCS) trial procedures declining by about 15.2%. Nevro also highlighted adjusted EBITDA guidance improvement to a range of negative $18 million to negative $16 million, an upgrade from the previous negative $20 million to negative $18 million. The company expects its cash position to further increase in the fourth quarter, leveraging cost savings from restructuring efforts.Cost Management and Restructuring Benefits
Net loss from operations decreased to $13.9 million from $25.6 million, and adjusted EBITDA improved to negative $1.8 million from a loss of $5.8 million due to restructuring and focus on expense management.
Cash Position Improvement
Cash, cash equivalents, and short-term investments increased by $3.3 million to $277 million, reflecting benefits from restructuring and strong working capital management.
HFX AdaptivAI Launch
FDA approval and limited market release of HFX AdaptivAI, which reduces charging requirements and improves clinical outcomes, leading to a 41% faster pain relief for patients.
Regulatory Approval in EU
Regulatory approval for HFX iQ in CE Mark countries, with a limited market release expected in select regions of the EU in late 2024 and full market release in Q1 2025.
SI Joint Fusion Product Advancements
Progress in SI joint fusion business with Nevro1 providing better opportunities for robust SI joint arthrodesis and positive feedback from physicians.
---
NVRO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
NVRO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 11, 2024 | $5.32 | $5.06 | -4.89% |
| Aug 06, 2024 | $8.69 | $4.83 | -44.42% |
| May 07, 2024 | $11.53 | $10.16 | -11.88% |
| Feb 21, 2024 | $16.59 | $16.51 | -0.48% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Nevro Corp (NVRO) report earnings?
Nevro Corp (NVRO) is schdueled to report earning on Feb 19, 2025, TBA Not Confirmed.
What is Nevro Corp (NVRO) earnings time?
Nevro Corp (NVRO) earnings time is at Feb 19, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NVRO EPS forecast?
NVRO EPS forecast for the fiscal quarter 2024 (Q4) is -0.78.
---